Showing 21 - 40 results of 8,992 for search '(( ((via step) OR (a step)) decrease ) OR ( i ((largest decrease) OR (larger decrease)) ))', query time: 0.51s Refine Results
  1. 21

    Image2_Biochanin A Regulates Key Steps of Inflammation Resolution in a Model of Antigen-Induced Arthritis via GPR30/PKA-Dependent Mechanism.TIF by Franciel Batista Felix (10699536)

    Published 2021
    “…BCA treatment shortened Ri from ∼23 h observed in vehicle-treated mice to ∼5.5 h, associated with an increase in apoptotic events and efferocytosis, both key steps for the resolution of inflammation. These effects of BCA were prevented by H89, an inhibitor of protein kinase A (PKA) and G15, a selective G protein–coupled receptor 30 (GPR30) antagonist. …”
  2. 22

    Image4_Biochanin A Regulates Key Steps of Inflammation Resolution in a Model of Antigen-Induced Arthritis via GPR30/PKA-Dependent Mechanism.TIF by Franciel Batista Felix (10699536)

    Published 2021
    “…BCA treatment shortened Ri from ∼23 h observed in vehicle-treated mice to ∼5.5 h, associated with an increase in apoptotic events and efferocytosis, both key steps for the resolution of inflammation. These effects of BCA were prevented by H89, an inhibitor of protein kinase A (PKA) and G15, a selective G protein–coupled receptor 30 (GPR30) antagonist. …”
  3. 23

    Image1_Biochanin A Regulates Key Steps of Inflammation Resolution in a Model of Antigen-Induced Arthritis via GPR30/PKA-Dependent Mechanism.TIF by Franciel Batista Felix (10699536)

    Published 2021
    “…BCA treatment shortened Ri from ∼23 h observed in vehicle-treated mice to ∼5.5 h, associated with an increase in apoptotic events and efferocytosis, both key steps for the resolution of inflammation. These effects of BCA were prevented by H89, an inhibitor of protein kinase A (PKA) and G15, a selective G protein–coupled receptor 30 (GPR30) antagonist. …”
  4. 24
  5. 25

    Long COVID prevalence decreases with vaccine uptake in the U.S. by Manlio De Domenico (626037)

    Published 2023
    “…<p>(A) Prevalence in U.S. states and the U.S. exhibits a decreasing trend with respect to vaccine uptake, both in the population vaccinated with at least one dose (top) and two doses (bottom), with the largest gap between 100% vaccinated and 100% unvaccinated scenarios observed in the reference population of adults who had COVID-19. …”
  6. 26
  7. 27

    Morphology Control of Lanthanide Doped NaGdF<sub>4</sub> Nanocrystals via One-Step Thermolysis by Miao Wang (248377)

    Published 2019
    “…The upconversion luminescence intensity decreased with increase of the surface to volume ratio of the upconverting nanocrystals, and a higher ratio of green to red emission was observed when the aspect ratio was close to 1. …”
  8. 28
  9. 29
  10. 30

    Distinct step kinematic parameters in lateral and rear legs. by Emma M. Anderson (19697573)

    Published 2024
    “…<p>A. Average stance duration decreased with increased walking speed, and was shorter in rear legs. …”
  11. 31

    Effective contact rate over time for the different modelling scenarios considered: fixed, continuously increasing, continuously decreasing and with a step-decrease. by Joshua Looker (21390948)

    Published 2025
    “…<p>Effective contact rate over time for the different modelling scenarios considered: fixed, continuously increasing, continuously decreasing and with a step-decrease.</p>…”
  12. 32

    Outcome variable descriptive statistics. by Kristen S. Regenauer (13842386)

    Published 2024
    “…SU stigma significantly decreased (<i>F</i>(1,16) = 18.94, <i>p</i> < 0.001, η<sub>p</sub><sup>2</sup> = 0.54). …”
  13. 33

    Demographic & job characteristics. by Kristen S. Regenauer (13842386)

    Published 2024
    “…SU stigma significantly decreased (<i>F</i>(1,16) = 18.94, <i>p</i> < 0.001, η<sub>p</sub><sup>2</sup> = 0.54). …”
  14. 34

    Training feedback. by Kristen S. Regenauer (13842386)

    Published 2024
    “…SU stigma significantly decreased (<i>F</i>(1,16) = 18.94, <i>p</i> < 0.001, η<sub>p</sub><sup>2</sup> = 0.54). …”
  15. 35

    Study flow. by Kristen S. Regenauer (13842386)

    Published 2024
    “…SU stigma significantly decreased (<i>F</i>(1,16) = 18.94, <i>p</i> < 0.001, η<sub>p</sub><sup>2</sup> = 0.54). …”
  16. 36
  17. 37
  18. 38
  19. 39
  20. 40